Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026 World's Most Admired Companies™ list, for the ...

| Quest Diagnostics emphases the critical role of in vitro diagnostics (IVDs) in shaping modern healthcare and advancing ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be ...

The arrangement serves as a case study for how outreach agreements can help hospital systems expand patient access to ...

In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Get the live share price of Quest Diagnostics Incorporated (DGX), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Shares of Quest Diagnostics Inc. DGX slipped 2.28% to $184.65 Wednesday, on what proved to be an all-around positive trading ...